Nanjing Vcare Made an Appearance at CPHI China 2023

2023-06-27

 

From June 19th to 21st, 2023, the 21st China International Pharmaceutical Ingredients Exhibition (CPHI China 2023) was held at the Shanghai New International Expo Center.

Nanjing Vcare as a domestic one-stop CRO/CDMO service and solution provider with a strong development momentum, made an appearance at this exhibition with heavyweight products such as characteristic active pharmaceutical ingredients, advanced intermediates, customized chemicals and the R&D and supply services of the whole CRO/CDMO industrial chain. It received high attention and recognition from domestic and foreign customers, fully demonstrating Nanjing Vcare's determination and achievements in all-round development with an international vision.

At this CPHI exhibition, the booth of Nanjing Vcare attracted wide attention and received more than 300 new and old customers from dozens of countries. They came to exchange information, negotiate and communicate, and the atmosphere was very lively. They deeply discussed the development prospects of the pharmaceutical industry and the layout planning for optimizing the industrial chain. While reaching cooperation intentions on the spot with most of these customers, it also laid a good foundation for further strengthening contacts and in-depth cooperation. The one-stop CRO/CDMO service model of "chemistry + pharmacy + medicine" of Nanjing Vcare was unanimously praised and recognized by customers through the careful and considerate explanations and patient and professional services of the staff.

Although this year's CPHI exhibition has come to an end, Nanjing Vcare has never stopped on the road of empowering the rapid development of global pharmaceutical enterprises and new drug R&D institutions. In the future, Nanjing Vcare will continue to adhere to innovation-driven development, deeply cultivate the R&D and production services throughout the whole industrial chain and the whole life cycle of drugs with an international vision, and help customers develop.

Prev

Wang Qiyang, Member of the Standing Committee of the Hubei Provincial Committee and Secretary of the Xiangyang Municipal Party Committee, Visited the Production Base of Nanjing Vcare for Inspection

Next

Nanjing Vcare Won the 10th Place in the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2023"